Trials / Unknown
UnknownNCT03354507
Use of Sodium Bicarbonate in Patients Treated With Topiramate
Use of Sodium Bicarbonate to Alkalinize Serum/Urine in Pediatric Patients Treated With Topiramate (Pilot Study)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- McMaster Children's Hospital · Academic / Other
- Sex
- All
- Age
- 2 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
Effect of oral sodium bicarbonate therapy on renal tubular acidosis in epilepsy patients taking topiramate.
Detailed description
Children on topiramate are at a risk of renal tubular acidosis and subsequent development of renal stones. Sodium bicarbonate has been shown to reduce renal tubular acidosis in other populations. To date, no data exist on the efficacy of correction of renal tubular acidosis in pediatric patients on topiramate. We are proposing to investigate the efficacy of 4 weeks of oral sodium bicarbonate therapy to reduce tubular acidosis in patients on topiramate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Sodium bicarbonate | Sodium bicarbonate. See arms. |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2017-11-28
- Last updated
- 2017-11-28
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03354507. Inclusion in this directory is not an endorsement.